glp 1 and vagus nerve Role of the gut–brain axis in energy glucose metabolism GLP-1 Agonists and the Vagus
Description
Depression was not a prominently reported adverse event, though comprehensive Phase 3 safety data are still awaited
10.1080/00365520802200028 79 GottschalckI
doi: 10.1172/jci.insight.140532 48 HindsCEPeaceEChenSDaviesIEl EidLTomasAet al
Regulatory Context: The telehealth weight loss and prescription compounding industries have been under increased regulatory scrutiny
With smaller appetites, GLP-1 users are focused on optimizing nutrition in every bite and sip
This suggested that the observational findings were likely influenced by preexisting differences, rather than the drugs themselves, said Ackley
